TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 49 filers reported holding TALARIS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58,136 | -7.6% | 20,689 | 0.0% | 0.00% | – |
| Q2 2023 | $62,895 | -42.9% | 20,689 | -64.7% | 0.00% | – |
| Q1 2023 | $110,091 | +84.3% | 58,559 | 0.0% | 0.00% | – |
| Q4 2022 | $59,731 | -65.5% | 58,559 | -11.0% | 0.00% | – |
| Q3 2022 | $173,000 | -34.7% | 65,806 | +12.1% | 0.00% | – |
| Q2 2022 | $265,000 | -54.8% | 58,694 | -1.6% | 0.00% | – |
| Q1 2022 | $586,000 | -28.3% | 59,622 | +11.6% | 0.00% | – |
| Q4 2021 | $817,000 | +119.6% | 53,424 | +94.8% | 0.00% | – |
| Q3 2021 | $372,000 | +51.2% | 27,422 | +63.4% | 0.00% | – |
| Q2 2021 | $246,000 | – | 16,779 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $5,513,299 | 6.67% |
| BML Capital Management, LLC | 1,929,484 | $3,627,430 | 3.14% |
| Western Standard LLC | 586,481 | $1,102,584 | 1.12% |
| Cormorant Asset Management, LP | 900,649 | $1,693 | 0.11% |
| Artal Group S.A. | 914,262 | $1,719 | 0.10% |
| Values First Advisors, Inc. | 52,896 | $99,445 | 0.06% |
| Blackstone Inc. | 8,089,315 | $15,207,912 | 0.06% |
| Eventide Asset Management | 1,561,092 | $2,934,853 | 0.05% |
| Marquette Asset Management, LLC | 101,375 | $190,585 | 0.05% |
| VIKING GLOBAL INVESTORS LP | 3,289,617 | $6,184,480 | 0.03% |